Researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, have discovered a mechanism by which cancer patients’ immune systems respond to chemotherapy. The new finding changes the current understanding of how the immune system responds to chemotherapy and could lead to opportunities for new treatments based on enhancing the body’s […]

A new study, using a unique detection method, has led scientists to identify several genes whose rearrangements in prostate cancer cells may play a role in the development and progression of the disease. Researchers at the University of Michigan, Ann Arbor, report that two genes, ETV1 and ERG, which previously were implicated as cancer-causing gene […]

Results from two large randomized clinical trials for patients with HER-2 positive invasive breast cancer show that those patients with early-stage breast cancer who received Herceptin® (trastuzumab) in combination with chemotherapy had a significant decrease in risk for breast cancer recurrence compared with patients who received the same chemotherapy without trastuzumab. Patients are considered “HER-2 […]

The National Cancer Institute (NCI), part of the National Institutes of Health, today announced the funding of a new initiative that will expand its efforts to understand the relationship between obesity and cancer. The Transdisciplinary Research on Energetics and Cancer (TREC) initiative will support a diverse team of scientists from across the United States. This […]

The nation’s leading cancer organizations report that Americans’ risk of dying from cancer continues to decline and that the rate of new cancers is holding steady. The “Annual Report to the Nation on the Status of Cancer, 1975-2002,” published in the Oct. 5, 2005, issue of the Journal of the National Cancer Institute*, shows observed […]